CD82 and breast cancer: However, KAI1-SP expression led to a pronounced EGF-R upregulation in both breast cancer cell types as compared to vector transfectants: in MDA-MB-231 cells by up to 4.4-fold; in MDA-MB-435 cells, which harbor appr.